Published in Eur J Pharmacol on January 26, 2008
Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct (2008) 1.54
Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res (2011) 1.28
Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) (2008) 1.28
Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol (2008) 1.14
Early-life stress disrupts attachment learning: the role of amygdala corticosterone, locus ceruleus corticotropin releasing hormone, and olfactory bulb norepinephrine. J Neurosci (2009) 1.12
Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol Res (2012) 1.10
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology (Berl) (2010) 1.03
Immediate and prolonged effects of alcohol exposure on the activity of the hypothalamic-pituitary-adrenal axis in adult and adolescent rats. Brain Behav Immun (2011) 0.97
Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration. J Neurosci (2014) 0.93
Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology (2010) 0.92
Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput Biol (2009) 0.90
The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol (2014) 0.90
The Effect of Acute and Chronic Social Stress on the Hippocampal Transcriptome in Mice. PLoS One (2015) 0.89
Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci (2011) 0.87
The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats. Brain Behav (2014) 0.86
Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists. J Endocrinol (2010) 0.84
Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine. Neuropsychopharmacology (2013) 0.81
Brain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drug. J Neuroendocrinol (2011) 0.81
Social stress increases expression of hemoglobin genes in mouse prefrontal cortex. BMC Neurosci (2014) 0.81
Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry. Brain Struct Funct (2013) 0.80
Stress: Neurobiology, consequences and management. J Pharm Bioallied Sci (2013) 0.79
Glucocorticoids regulation of FosB/ΔFosB expression induced by chronic opiate exposure in the brain stress system. PLoS One (2012) 0.77
Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal. PLoS One (2012) 0.76
Hypothalamic KISS1 expression, gonadotrophin-releasing hormone and neurotransmitter innervation vary with stress and sensitivity in macaques. J Neuroendocrinol (2014) 0.76
Stress-sensitive neurosignalling in depression: an integrated network biology approach to candidate gene selection for genetic association analysis. Ment Illn (2012) 0.76
Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells. Front Endocrinol (Lausanne) (2016) 0.75
Chronic stress improves NO- and Ca2+ flux-dependent vascular function: a pharmacological study. Arq Bras Cardiol (2015) 0.75
Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm. Psychopharmacology (Berl) (2012) 0.75
The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol (1999) 3.10
Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev (1991) 3.07
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev (1991) 2.85
Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science (1984) 2.83
Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry (1999) 2.39
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther (2004) 1.92
Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res (1991) 1.88
The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science (1986) 1.75
Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biol Psychiatry (2001) 1.65
Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol (1998) 1.56
Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res (1983) 1.54
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians (1999) 1.41
Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther (1997) 1.34
Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol (1996) 1.33
Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci (2004) 1.31
Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev (1989) 1.24
Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem (1993) 1.22
The role of CRH in behavioral responses to stress. Peptides (2001) 1.18
Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann N Y Acad Sci (2004) 1.17
Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog Neuropsychopharmacol Biol Psychiatry (1998) 1.17
Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav (2001) 1.13
Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) (2003) 1.11
Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav Brain Res (2007) 1.10
Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience (1995) 1.08
Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience (1992) 1.07
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry (1999) 1.04
Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse (1999) 1.02
Phasic activation of locus ceruleus neurons by the central nucleus of the amygdala. J Neurosci (2003) 0.97
Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav (1993) 0.96
Adrenergic mechanisms in the control of corticotrophin secretion. J Endocrinol (1988) 0.90
Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study. Brain Res (1992) 0.90
Endocrine disturbances in depression. J Endocrinol Invest (2005) 0.89
Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons. Brain Res (1996) 0.89
Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J Neuroendocrinol (1993) 0.89
Effects of chronic footshock, restraint and corticotropin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats. Behav Brain Res (2007) 0.89
CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry (1987) 0.88
Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol (1993) 0.87
Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann N Y Acad Sci (2008) 0.87
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry (1983) 0.86
The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats. J Pharmacol Exp Ther (1990) 0.85
Adrenergic control of the secretion of anterior pituitary hormones. Baillieres Clin Endocrinol Metab (1993) 0.85
Electrophysiology and neuropharmacology of noradrenergic projections to rat PVN magnocellular neurons. Am J Physiol (1993) 0.85
Chronic restraint stress elicits a positive antidepressant response on the forced swim test. Eur J Pharmacol (1982) 0.84
Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res Bull (1995) 0.84
Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul Pept (1986) 0.83
Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav (1987) 0.83
Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry. Brain Res Bull (1998) 0.83
Olfactory bulbectomy enhances sensitization of the acoustic startle reflex produced by acute or repeated stress. Behav Neurosci (1997) 0.80
Stress produces opioid-like effects on investigatory behavior. Pharmacol Biochem Behav (1985) 0.80
Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal. Pharmacol Biochem Behav (1990) 0.80
Corticotropin-releasing factor enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis. Brain Res (1993) 0.80
Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav (1993) 0.80
Hippocampal noradrenergic responses to CRF injected into the locus coeruleus of unanesthetized rats. Brain Res (2002) 0.80
Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry (1987) 0.79
CRF facilitates NE release from the hippocampus: a microdialysis study. Neurosci Res (1994) 0.79
Adrenalectomy augments in vivo release of norepinephrine in the paraventricular nucleus during immobilization stress. Endocrinology (1993) 0.79
Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats. Neurochem Int (2008) 0.79
Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus. Brain Res Bull (2000) 0.78
Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study. Neuroendocrinology (1996) 0.78
Corticotropin-releasing factor neurotransmission in locus coeruleus: a possible site of antidepressant action. Brain Res Bull (1994) 0.78
CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression. Biol Psychiatry (1988) 0.78
Modulation by corticotropin-releasing factor of monoamine metabolism in the lateral hypothalamus. Neurosci Lett (1989) 0.76
Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev (2005) 1.89
Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.72
Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav (2005) 1.40
Serotonergic hypothesis of sleepwalking. Med Hypotheses (2005) 1.03
Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol Behav (2005) 1.02
Epigenetics of stress adaptations in the brain. Brain Res Bull (2013) 1.00
The usage of video analysis system for detection of immobility in the tail suspension test in mice. Pharmacol Biochem Behav (2006) 0.87
Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann N Y Acad Sci (2008) 0.87
Effects of chronic stress on prefrontal cortex transcriptome in mice displaying different genetic backgrounds. J Mol Neurosci (2012) 0.86
Computer assisted video analysis of swimming performance in a forced swim test: simultaneous assessment of duration of immobility and swimming style in mice selected for high and low swim-stress induced analgesia. Physiol Behav (2008) 0.82
Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation (2006) 0.81
Effect of chronic mild stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and displaying different emotional behaviors. Eur Neuropsychopharmacol (2010) 0.80
Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice. BMC Neurosci (2013) 0.80
Hippocampal noradrenergic responses to CRF injected into the locus coeruleus of unanesthetized rats. Brain Res (2002) 0.80
Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland. J Psychoactive Drugs (2013) 0.79
Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett (2010) 0.78
Differences in ethanol drinking between mice selected for high and low swim stress-induced analgesia. Alcohol (2008) 0.77
Selection for stress-induced analgesia affects the mouse hippocampal transcriptome. J Mol Neurosci (2011) 0.77
Lipopolysaccharide does not affect acoustic startle reflex in mice. Brain Behav Immun (2007) 0.76
Alcohol reverses depressive and pronociceptive effects of chronic stress in mice with enhanced activity of the opioid system. Acta Neurobiol Exp (Wars) (2009) 0.76
Genetic and Epigenetic Mechanisms Linking Pain and Psychiatric Disorders. Mod Trends Pharmacopsychiatri (2015) 0.75
Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone. Int Immunopharmacol (2010) 0.75
Opposite effects of alcohol in regulating stress-induced changes in body weight between the two mouse lines with enhanced or low opioid system activity. Physiol Behav (2010) 0.75